ArticleOncogenesis2022

Heparanase modulates the prognosis and development of BRAF V600E-mutant colorectal cancer by regulating AKT/p27Kip1/Cyclin E2 pathway.

Mengling Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.